查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1264181

分子品管的全球市場預測:各產品類型、分析物類型、用途、終端用戶 - 產業的成長與需求預測(～2030年)

Molecular Quality Controls Market Outlook by Product Type, Analyte Type, Application, End User - Global Industry Growth and Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

全球分子品管的市場規模，從2022年的1億9,120萬美元到2030年預計達到3億1,370萬美元，今後數年以6.4％的年複合成長率成長。由於檢定臨床檢驗室增加，分子品管的需求預計今後數年增加。

本報告提供全球分子品管市場相關調查分析，市場動態，各地區與市場區隔的市場收益，競爭情形等資訊。

目錄

第1章 調查的範圍

第2章 調查手法

第3章 摘要整理

第4章 產業的專家/KOL的迴響

第5章 市場指標

第6章 產業預測

  • 市場動態
    • 趨勢
    • 促進因素
    • 阻礙因素/課題
    • 促進因素/阻礙因素的影響的分析
  • COVID-19影響
  • 波特的五力分析

第7章 全球市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各地區(2017年～2030年)

第8章 北美市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各國(2017年～2030年)

第9章 歐洲市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各國(2017年～2030年)

第10章 亞太地區市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各國(2017年～2030年)

第11章 南美市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各國(2017年～2030年)

第12章 中東、非洲市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)
  • 市場收益:各國(2017年～2030年)

第13章 美國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第14章 加拿大市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第15章 德國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第16章 法國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第17章 英國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第18章 義大利市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第19章 西班牙市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第20章 日本市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第21章 中國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第22章 印度市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第23章 澳洲市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第24章 韓國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第25章 巴西市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第26章 墨西哥市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第27章 沙烏地阿拉伯市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第28章 南非市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第29章 阿拉伯聯合大公國市場

  • 概要
  • 市場收益:各產品類型(2017年～2030年)
  • 市場收益:各分析物(2017年～2030年)
  • 市場收益:各用途(2017年～2030年)
  • 市場收益:各終端用戶(2017年～2030年)

第30章 競爭情形

  • 市場參與企業與其產品的清單
  • 主要企業的競爭基準
  • 主要企業的產品基準
  • 最近的策略性發展

第31章 企業簡介

  • LGC Limited
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • ZeptoMetrix LLC
  • Quidel Corporation
  • Maine Molecular Quality Controls Inc.
  • Microbiologics Inc.
  • Bio-Techne Corporation
  • Qnostics Ltd.
  • Fortress Diagnostics
  • LGC Clinical Diagnostics Inc.
  • Microbix Biosystems Inc.
  • bioMerieux SA
  • Anchor Molecular

第32章 附錄

Product Code: 12522

The total size of the molecular quality controls market was USD 191.2 million in 2022, which will reach USD 313.7 million by 2030, propelling at a rate of 6.4% in the years to come, as per a statement by P&S Intelligence.

The independent controls category had the largest share of about 40% in 2022. This is due to the fact that they are produced independently of calibrators, instruments, and reagents, and tests have the supreme sensitivity rate as a result of their tremendously precise, unbiased, and independent valuation of a testing system's or technique's performance.

The single-analyte controls category had a share of over 60%, in 2022, and it will maintain the same in the years to come. This is for the reason that hospitals often use singleplex assays; and with the use of single-analyte, they have benefits for example, easy investigation and understanding and decreased chance of cross-responsiveness, amongst others.

Multi-analyte will witness stable growth rate, about 7%, in the years to come. This can be owing to the progressions in tech and the expansion of new multi-analyte and multi-instrument controls. Clinical labs can save money by the use of these state-of-the-art devices, which integrate frequent instrument-specific controls into a single instrument.

Additionally, by doing away with the necessity for separate quality control actions for each analyte, these controls are responsible for less time consumption.

The diagnostic labs dominated the molecular quality controls market, about 35%, in 2022.

This is due to the fact that the existence of numerous accredited labs in dissimilar regions, which concentrates in services with the use of molecular technology; QC procedures are employed more frequently; regulatory actions are happening more regularly; molecular diagnostics are becoming more expensive; and Alzheimer, diabetes, and cancer cases are increasing, leading to the opening up of numerous labs every year.

North America dominated the industry with about 45%, in 2022. This is because of the high incorporation of leading-edge infra, the enhanced quantity of diagnostic facilities, and the improved count of authorized clinical labs in the region.

Furthermore, the cutting-edge medical facilities in Canada and the U.S., the existence of top manufacturers, and easy access to improved products and techs drive the regional market. In North America, the U.S. has a higher revenue due to large patient population.

Europe follows North America. This is chiefly credited to the snowballing cancer research and related biomarkers and the increasing cancer cases. A study has claimed that there will be a boom in cancer prevalence in Europe, because of the increasing elderly population, as they are prone to long-lasting ailments.

It is because of the increasing count of accredited clinical labs, the demand for molecular quality control will be on the rise in the years to come.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product type
    • 1.4.2. Market size breakdown, by analyte type
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by end user
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

  • 6.1. Market Dynamics
    • 6.1.1. Trends
    • 6.1.2. Drivers
    • 6.1.3. Restraints/challenges
    • 6.1.4. Impact analysis of drivers/restraints
  • 6.2. Impact of COVID-19
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Bargaining power of buyers
    • 6.3.2. Bargaining power of suppliers
    • 6.3.3. Threat of new entrants
    • 6.3.4. Intensity of rivalry
    • 6.3.5. Threat of substitutes

Chapter 7. Global Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product Type (2017-2030)
    • 7.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 7.3. Market Revenue, by Analyte Type (2017-2030)
  • 7.4. Market Revenue, by Application (2017-2030)
  • 7.5. Market Revenue, by End User (2017-2030)
  • 7.6. Market Revenue, by Region (2017-2030)

Chapter 8. North America Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product Type (2017-2030)
    • 8.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 8.3. Market Revenue, by Analyte Type (2017-2030)
  • 8.4. Market Revenue, by Application (2017-2030)
  • 8.5. Market Revenue, by End User (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. Europe Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product Type (2017-2030)
    • 9.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 9.3. Market Revenue, by Analyte Type (2017-2030)
  • 9.4. Market Revenue, by Application (2017-2030)
  • 9.5. Market Revenue, by End User (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. APAC Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product Type (2017-2030)
    • 10.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 10.3. Market Revenue, by Analyte Type (2017-2030)
  • 10.4. Market Revenue, by Application (2017-2030)
  • 10.5. Market Revenue, by End User (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. LATAM Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product Type (2017-2030)
    • 11.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 11.3. Market Revenue, by Analyte Type (2017-2030)
  • 11.4. Market Revenue, by Application (2017-2030)
  • 11.5. Market Revenue, by End User (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. MEA Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product Type (2017-2030)
    • 12.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 12.3. Market Revenue, by Analyte Type (2017-2030)
  • 12.4. Market Revenue, by Application (2017-2030)
  • 12.5. Market Revenue, by End User (2017-2030)
  • 12.6. Market Revenue, by Country (2017-2030)

Chapter 13. U.S. Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product Type (2017-2030)
    • 13.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 13.3. Market Revenue, by Analyte Type (2017-2030)
  • 13.4. Market Revenue, by Application (2017-2030)
  • 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Canada Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product Type (2017-2030)
    • 14.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 14.3. Market Revenue, by Analyte Type (2017-2030)
  • 14.4. Market Revenue, by Application (2017-2030)
  • 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. Germany Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product Type (2017-2030)
    • 15.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 15.3. Market Revenue, by Analyte Type (2017-2030)
  • 15.4. Market Revenue, by Application (2017-2030)
  • 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. France Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product Type (2017-2030)
    • 16.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 16.3. Market Revenue, by Analyte Type (2017-2030)
  • 16.4. Market Revenue, by Application (2017-2030)
  • 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. U.K. Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product Type (2017-2030)
    • 17.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 17.3. Market Revenue, by Analyte Type (2017-2030)
  • 17.4. Market Revenue, by Application (2017-2030)
  • 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Italy Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product Type (2017-2030)
    • 18.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 18.3. Market Revenue, by Analyte Type (2017-2030)
  • 18.4. Market Revenue, by Application (2017-2030)
  • 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Spain Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product Type (2017-2030)
    • 19.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 19.3. Market Revenue, by Analyte Type (2017-2030)
  • 19.4. Market Revenue, by Application (2017-2030)
  • 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. Japan Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product Type (2017-2030)
    • 20.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 20.3. Market Revenue, by Analyte Type (2017-2030)
  • 20.4. Market Revenue, by Application (2017-2030)
  • 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. China Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product Type (2017-2030)
    • 21.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 21.3. Market Revenue, by Analyte Type (2017-2030)
  • 21.4. Market Revenue, by Application (2017-2030)
  • 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. India Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product Type (2017-2030)
    • 22.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 22.3. Market Revenue, by Analyte Type (2017-2030)
  • 22.4. Market Revenue, by Application (2017-2030)
  • 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. Australia Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product Type (2017-2030)
    • 23.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 23.3. Market Revenue, by Analyte Type (2017-2030)
  • 23.4. Market Revenue, by Application (2017-2030)
  • 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. South Korea Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product Type (2017-2030)
    • 24.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 24.3. Market Revenue, by Analyte Type (2017-2030)
  • 24.4. Market Revenue, by Application (2017-2030)
  • 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Brazil Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product Type (2017-2030)
    • 25.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 25.3. Market Revenue, by Analyte Type (2017-2030)
  • 25.4. Market Revenue, by Application (2017-2030)
  • 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Mexico Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product Type (2017-2030)
    • 26.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 26.3. Market Revenue, by Analyte Type (2017-2030)
  • 26.4. Market Revenue, by Application (2017-2030)
  • 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. Saudi Arabia Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product Type (2017-2030)
    • 27.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 27.3. Market Revenue, by Analyte Type (2017-2030)
  • 27.4. Market Revenue, by Application (2017-2030)
  • 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. South Africa Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product Type (2017-2030)
    • 28.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 28.3. Market Revenue, by Analyte Type (2017-2030)
  • 28.4. Market Revenue, by Application (2017-2030)
  • 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. U.A.E. Market

  • 29.1. Overview
  • 29.2. Market Revenue, by Product Type (2017-2030)
    • 29.2.1. Instrument-specific controls market revenue, by type (2017-2030)
  • 29.3. Market Revenue, by Analyte Type (2017-2030)
  • 29.4. Market Revenue, by Application (2017-2030)
  • 29.5. Market Revenue, by End User (2017-2030)

Chapter 30. Competitive Landscape

  • 30.1. List of Market Players and their Offerings
  • 30.2. Competitive Benchmarking of Key Players
  • 30.3. Product Benchmarking of Key Players
  • 30.4. Recent Strategic Developments

Chapter 31. Company Profiles

  • 31.1. LGC Limited
    • 31.1.1. Business overview
    • 31.1.2. Product and service offerings
  • 31.2. Thermo Fisher Scientific Inc.
    • 31.2.1. Business overview
    • 31.2.2. Product and service offerings
    • 31.2.3. Key financial summary
  • 31.3. Bio-Rad Laboratories Inc.
    • 31.3.1. Business overview
    • 31.3.2. Product and service offerings
    • 31.3.3. Key financial summary
  • 31.4. F. Hoffmann-La Roche Ltd.
    • 31.4.1. Business overview
    • 31.4.2. Product and service offerings
    • 31.4.3. Key financial summary
  • 31.5. ZeptoMetrix LLC
    • 31.5.1. Business overview
    • 31.5.2. Product and service offerings
  • 31.6. Quidel Corporation
    • 31.6.1. Business overview
    • 31.6.2. Product and service offerings
    • 31.6.3. Key financial summary
  • 31.7. Maine Molecular Quality Controls Inc.
    • 31.7.1. Business overview
    • 31.7.2. Product and service offerings
  • 31.8. Microbiologics Inc.
    • 31.8.1. Business overview
    • 31.8.2. Product and service offerings
  • 31.9. Bio-Techne Corporation
    • 31.9.1. Business overview
    • 31.9.2. Product and service offerings
    • 31.9.3. Key financial summary
  • 31.10. Qnostics Ltd.
    • 31.10.1. Business overview
    • 31.10.2. Product and service offerings
  • 31.11. Fortress Diagnostics
    • 31.11.1. Business overview
    • 31.11.2. Product and service offerings
  • 31.12. LGC Clinical Diagnostics Inc.
    • 31.12.1. Business overview
    • 31.12.2. Product and service offerings
  • 31.13. Microbix Biosystems Inc.
    • 31.13.1. Business overview
    • 31.13.2. Product and service offerings
    • 31.13.3. Key financial summary
  • 31.14. bioMerieux SA
    • 31.14.1. Business overview
    • 31.14.2. Product and service offerings
    • 31.14.3. Key financial summary
  • 31.15. Anchor Molecular
    • 31.15.1. Business overview
    • 31.15.2. Product and service offerings

Chapter 32. Appendix

  • 32.1. Abbreviations
  • 32.2. Sources and References
  • 32.3. Related Reports

LIST OF FIGURES

  • FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)
  • FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY
  • FIG 9 BARGAINING POWER OF BUYERS
  • FIG 10 BARGAINING POWER OF SUPPLIERS
  • FIG 11 THREAT OF NEW ENTRANTS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M
  • FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017-2030)
  • FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017-2030)
  • FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017-2030)
  • FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017-2030)
  • FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017-2030)
  • FIG 118 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 119 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 120 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 121 QUIDEL CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 122 BIO-TECHNE CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 123 MICROBIX BIOSYSTEMS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
  • FIG 124 BIOMERIEUX SA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)